Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01365494
What this trial is testing

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

Who this might be right for
Rabies
Novartis Vaccines 250
Early research (Phase 1)Study completedNCT02015091
What this trial is testing

Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 141
Not applicableUnknownNCT05140720
What this trial is testing

Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age

Who this might be right for
Streptococcus PneumoniaVaccine Preventable Disease
Vabiotech 300
Early research (Phase 1)Study completedNCT01273246
What this trial is testing

Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children

Who this might be right for
Hand-foot-mouth DiseaseInfection; Viral, Enterovirus
Sinovac Biotech Co., Ltd 132
Large-scale testing (Phase 3)Study completedNCT00196924
What this trial is testing

Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 2,067
Early research (Phase 1)Study completedNCT00127803
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

Who this might be right for
Clostridium Infections
Sanofi 50
Large-scale testing (Phase 3)Study completedNCT00140686
What this trial is testing

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 3,994
Large-scale testing (Phase 3)Study completedNCT04176939
What this trial is testing

Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

Who this might be right for
Herpes Zoster
GlaxoSmithKline 68
Testing effectiveness (Phase 2)Ended earlyNCT03815942
What this trial is testing

VAccination in Early and ADvanced Prostate caNCEr

Who this might be right for
Intermediate Risk Prostate CancerCastration-resistant Prostate Cancer
University of Oxford 23
Early research (Phase 1)Active Not RecruitingNCT06732583
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years

Who this might be right for
Tuberculosis
CanSino Biologics Inc. 36
Not applicableWithdrawnNCT05587881
What this trial is testing

Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Diseases
The First Affiliated Hospital of Soochow University
Early research (Phase 1)Study completedNCT02867319
What this trial is testing

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

Who this might be right for
Meningococcal
Beijing Chaoyang District Centre for Disease Control and Prevention 60
Testing effectiveness (Phase 2)Study completedNCT02873286
What this trial is testing

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 420
Testing effectiveness (Phase 2)Study completedNCT04444622
What this trial is testing

Immunotherapy for Third Line Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Mirror Biologics, Inc. 29
Large-scale testing (Phase 3)Study completedNCT00637195
What this trial is testing

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 152
Testing effectiveness (Phase 2)Study completedNCT02515227
What this trial is testing

Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab

Who this might be right for
Melanoma
Craig L Slingluff, Jr 22
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Early research (Phase 1)Study completedNCT04742842
What this trial is testing

The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers

Who this might be right for
SARS-CoV2 COVID-19
University of Sydney 68
Post-approval studies (Phase 4)Study completedNCT07710586
What this trial is testing

Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China

Who this might be right for
Influenza Vaccine
Ab&B Bio-tech Co., Ltd.JS 3,105
Testing effectiveness (Phase 2)Study completedNCT05252845
What this trial is testing

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

Who this might be right for
Malaria,Falciparum
University of Oxford 127
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation